1
|
Islam A, Ferdous J, Islam S, Sayeed MA, Dutta Choudhury S, Saha O, Hassan MM, Shirin T. Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife. Viruses 2021; 13:1908. [PMID: 34696338 PMCID: PMC8537103 DOI: 10.3390/v13101908] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2021] [Revised: 09/12/2021] [Accepted: 09/17/2021] [Indexed: 12/21/2022] Open
Abstract
Diverse coronavirus (CoV) strains can infect both humans and animals and produce various diseases. CoVs have caused three epidemics and pandemics in the last two decades, and caused a severe impact on public health and the global economy. Therefore, it is of utmost importance to understand the emergence and evolution of endemic and emerging CoV diversity in humans and animals. For diverse bird species, the Infectious Bronchitis Virus is a significant one, whereas feline enteric and canine coronavirus, recombined to produce feline infectious peritonitis virus, infects wild cats. Bovine and canine CoVs have ancestral relationships, while porcine CoVs, especially SADS-CoV, can cross species barriers. Bats are considered as the natural host of diverse strains of alpha and beta coronaviruses. Though MERS-CoV is significant for both camels and humans, humans are nonetheless affected more severely. MERS-CoV cases have been reported mainly in the Arabic peninsula since 2012. To date, seven CoV strains have infected humans, all descended from animals. The severe acute respiratory syndrome coronaviruses (SARS-CoV and SARS-CoV-2) are presumed to be originated in Rhinolopoid bats that severely infect humans with spillover to multiple domestic and wild animals. Emerging alpha and delta variants of SARS-CoV-2 were detected in pets and wild animals. Still, the intermediate hosts and all susceptible animal species remain unknown. SARS-CoV-2 might not be the last CoV to cross the species barrier. Hence, we recommend developing a universal CoV vaccine for humans so that any future outbreak can be prevented effectively. Furthermore, a One Health approach coronavirus surveillance should be implemented at human-animal interfaces to detect novel coronaviruses before emerging to humans and to prevent future epidemics and pandemics.
Collapse
Affiliation(s)
- Ariful Islam
- EcoHealth Alliance, New York, NY 10001-2320, USA; (J.F.); (S.I.); (M.A.S.); (S.D.C.)
- Centre for Integrative Ecology, School of Life and Environmental Science, Deakin University, Burwood, VIC 3216, Australia
- Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka 1212, Bangladesh;
| | - Jinnat Ferdous
- EcoHealth Alliance, New York, NY 10001-2320, USA; (J.F.); (S.I.); (M.A.S.); (S.D.C.)
- Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka 1212, Bangladesh;
- School of Veterinary Science, The University of Queensland, Gatton, QLD 4343, Australia
| | - Shariful Islam
- EcoHealth Alliance, New York, NY 10001-2320, USA; (J.F.); (S.I.); (M.A.S.); (S.D.C.)
- Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka 1212, Bangladesh;
| | - Md. Abu Sayeed
- EcoHealth Alliance, New York, NY 10001-2320, USA; (J.F.); (S.I.); (M.A.S.); (S.D.C.)
- Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka 1212, Bangladesh;
| | - Shusmita Dutta Choudhury
- EcoHealth Alliance, New York, NY 10001-2320, USA; (J.F.); (S.I.); (M.A.S.); (S.D.C.)
- Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka 1212, Bangladesh;
| | - Otun Saha
- Department of Microbiology, University of Dhaka, Dhaka 1000, Bangladesh;
| | - Mohammad Mahmudul Hassan
- Faculty of Veterinary Medicine, Chattogram Veterinary and Animal Sciences University, Chattogram 4225, Bangladesh;
| | - Tahmina Shirin
- Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka 1212, Bangladesh;
| |
Collapse
|
2
|
De Luca E, Sautto GA, Crisi PE, Lorusso A. Feline Morbillivirus Infection in Domestic Cats: What Have We Learned So Far? Viruses 2021; 13:v13040683. [PMID: 33921104 PMCID: PMC8071394 DOI: 10.3390/v13040683] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Revised: 04/13/2021] [Accepted: 04/13/2021] [Indexed: 11/16/2022] Open
Abstract
Feline morbillivirus (FeMV) was identified for the first time in stray cats in 2012 in Hong Kong and, since its discovery, it was reported in domestic cats worldwide. Although a potential association between FeMV infection and tubulointerstitial nephritis (TIN) has been suggested, this has not been proven, and the subject remains controversial. TIN is the most frequent histopathological finding in the context of feline chronic kidney disease (CKD), which is one of the major clinical pathologies in feline medicine. FeMV research has mainly focused on defining the epidemiology, the role of FeMV in the development of CKD, and its in vitro tropism, but the pathogenicity of FeMV is still not clear, partly due to its distinctive biological characteristics, as well as to a lack of a cell culture system for its rapid isolation. In this review, we summarize the current knowledge of FeMV infection, including genetic diversity of FeMV strains, epidemiology, pathogenicity, and clinicopathological findings observed in naturally infected cats.
Collapse
Affiliation(s)
- Eliana De Luca
- Istituto Zooprofilattico Sperimentale dell’Abruzzo e Molise (IZSAM), 64100 Teramo, Italy;
| | | | - Paolo Emidio Crisi
- Faculty of Veterinary Medicine, Veterinary University Hospital, University of Teramo, 64100 Teramo, Italy;
| | - Alessio Lorusso
- Istituto Zooprofilattico Sperimentale dell’Abruzzo e Molise (IZSAM), 64100 Teramo, Italy;
- Correspondence: ; Tel.: +39-0861332440
| |
Collapse
|
3
|
Zappulli V, Ferro S, Bonsembiante F, Brocca G, Calore A, Cavicchioli L, Centelleghe C, Corazzola G, De Vreese S, Gelain ME, Mazzariol S, Moccia V, Rensi N, Sammarco A, Torrigiani F, Verin R, Castagnaro M. Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective. Animals (Basel) 2020; 10:E2377. [PMID: 33322366 PMCID: PMC7764021 DOI: 10.3390/ani10122377] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 12/04/2020] [Accepted: 12/09/2020] [Indexed: 12/13/2022] Open
Abstract
Coronaviruses (CoVs) are worldwide distributed RNA-viruses affecting several species, including humans, and causing a broad spectrum of diseases. Historically, they have not been considered a severe threat to public health until two outbreaks of COVs-related atypical human pneumonia derived from animal hosts appeared in 2002 and in 2012. The concern related to CoVs infection dramatically rose after the COVID-19 global outbreak, for which a spill-over from wild animals is also most likely. In light of this CoV zoonotic risk, and their ability to adapt to new species and dramatically spread, it appears pivotal to understand the pathophysiology and mechanisms of tissue injury of known CoVs within the "One-Health" concept. This review specifically describes all CoVs diseases in animals, schematically representing the tissue damage and summarizing the major lesions in an attempt to compare and put them in relation, also with human infections. Some information on pathogenesis and genetic diversity is also included. Investigating the lesions and distribution of CoVs can be crucial to understand and monitor the evolution of these viruses as well as of other pathogens and to further deepen the pathogenesis and transmission of this disease to help public health preventive measures and therapies.
Collapse
Affiliation(s)
- Valentina Zappulli
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Silvia Ferro
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Federico Bonsembiante
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
- Department of Animal Medicine, Productions and Health, University of Padua, Legnaro, 35020 Padua, Italy
| | - Ginevra Brocca
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Alessandro Calore
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Laura Cavicchioli
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Cinzia Centelleghe
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Giorgia Corazzola
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Steffen De Vreese
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
- Laboratory of Applied Bioacoustics, Technical University of Catalunya, BarcelonaTech, Vilanova i la Geltrù, 08800 Barcelona, Spain
| | - Maria Elena Gelain
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Sandro Mazzariol
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Valentina Moccia
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Nicolò Rensi
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Alessandro Sammarco
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
- Department of Neurology and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA
| | - Filippo Torrigiani
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Ranieri Verin
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| | - Massimo Castagnaro
- Department of Comparative Biomedicine and Food Science, University of Padua, Legnaro, 35020 Padua, Italy; (V.Z.); (F.B.); (G.B.); (A.C.); (L.C.); (C.C.); (G.C.); (S.D.V.); (M.E.G.); (S.M.); (V.M.); (N.R.); (A.S.); (F.T.); (R.V.); (M.C.)
| |
Collapse
|
4
|
Abstract
Urogenital lesions are relatively common in ferrets. Renal disease is diagnosed as in traditional small animal medicine; however, peculiarities in ferrets include physiologically low levels of creatinine. Renal cysts are very common in ferrets but are usually incidental findings. Uroliths are usually composed of struvite or cystine. Urethral obstruction in male ferrets is predominantly caused by adrenal-associated prostatic disease. Spontaneous cystitis is rare in ferrets. Primary reproductive disease is uncommon in ferrets in the United States where animals are usually neutered at 6 weeks of age. In other countries, ferrets either remain unneutered or are neutered at 5 to 6 months of age. Ferrets are seasonal breeders, and female are induced ovulators. Prolonged estrus and hyperestrogenism often causes profound bone marrow suppression.
Collapse
|
5
|
Donovan KM, Leidinger MR, McQuillen LP, Goeken JA, Hogan CM, Harwani SC, Flaherty HA, Meyerholz DK. Allograft Inflammatory Factor 1 as an Immunohistochemical Marker for Macrophages in Multiple Tissues and Laboratory Animal Species. Comp Med 2018; 68:341-348. [PMID: 30227902 DOI: 10.30802/aalas-cm-18-000017] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Allograft inflammatory factor 1 (AIF1) is a commonly used marker for microglia in the brains of humans and some animal models but has had limited applications elsewhere. We sought to determine whether AIF1 can be used as a macrophage marker across common laboratory animal species and tissues. We studied tissues (that is, spleen, liver, and lung) with defined macrophage populations by using an AIF1 immunostaining technique previously validated in human tissue. Tissues were collected from various mouse strains (n = 20), rat strains (n = 15), pigs (n = 4), ferrets (n = 4), and humans (n = 4, lung only). All samples of liver had scattered immunostaining in interstitial cells, consistent with resident tissue macrophages (Kupffer cells). Spleen samples had cellular immunostaining of macrophages in both the red and white pulp compartments, but the red pulp had more immunostained cellular aggregates and, in some species, increased immunostaining intensity compared with white pulp. In lung, alveolar macrophages had weak to moderate staining, whereas interstitial and perivascular macrophages demonstrated moderate to robust staining. Incidental lesions and tissue changes were detected in some sections, including a tumor, inducible bronchus-associated lymphoid tissue, and inflammatory lesions that demonstrated AIF1 immunostaining of macrophages. Finally, we compared AIF1 immunostaining of alveolar macrophages between a hypertensive rat model (SHR strain) and a normotensive model (WKY strain). SHR lungs had altered intensity and distribution of immunostaining in activated macrophages compared with macrophages of WKY lungs. Overall, AIF1 immunostaining demonstrated reproducible macrophage staining across multiple species and tissue types. Given the increasing breadth of model species used to study human disease, the use of cross-species markers and techniques can reduce some of the inherent variability within translational research.
Collapse
Affiliation(s)
| | | | | | - J Adam Goeken
- Departments of Pathology, University of Iowa, Iowa City, Iowa, USA
| | | | - Sailesh C Harwani
- Departments of Internal Medicine, University of Iowa, Iowa City, Iowa, USA
| | - Heather A Flaherty
- Department of Veterinary Pathology, Iowa State University, Ames, Iowa, USA
| | | |
Collapse
|
6
|
Wills SE, Beaufrère HH, Brisson BA, Fraser RS, Smith DA. Pancreatitis and Systemic Coronavirus Infection in a Ferret ( Mustela putorius furo). Comp Med 2018; 68:208-211. [PMID: 29776456 PMCID: PMC6008714 DOI: 10.30802/aalas-cm-17-000109] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2017] [Revised: 12/26/2017] [Accepted: 12/27/2017] [Indexed: 11/05/2022]
Abstract
A 1-y-old spayed female ferret (Mustela putorius furo) was referred for additional diagnostic evaluation after physical examination by the referring veterinarian revealed a cranial abdominal mass. The ferret had a 2-wk history of inappetence, weight loss, and lethargy. On presentation, the ferret was thin, and an approximately 3-cm mass was palpable in the cranial abdomen. No other abnormalities were noted. Abdominal ultrasonography confirmed the presence of a soft-tissue structure, with a moderate blood supply and mesenteric lymphadenopathy. Fine-needle aspirates of the mass were nondiagnostic. Exploratory laparotomy revealed multiple nodules and thickened tissues throughout the mesentery, a thickened and nodular pancreas, and a small amount of free abdominal fluid. Histopathology of mesenteric, lymphatic, and pancreatic biopsies revealed suppurative pancreatitis and necrotizing and pyogranulomatous mesenteric steatitis. Positive immunohistochemistry for feline coronavirus confirmed a diagnosis of ferret systemic coronavirus disease (FSCD). The ferret was treated medically with oral prednisolone, improved dramatically, and was still doing well 22 mo after diagnosis. Although FSCD has been reported extensively, this case is noteworthy for the presence of suppurative pancreatitis and the positive long-term outcome after corticosteroid therapy.
Collapse
Affiliation(s)
- Sarah E Wills
- Exotic Animal Care Centre, Pasadena, California, USA; Ontario Veterinary College, University of Guelph, Ontario, Canada
| | - Hugues H Beaufrère
- Departments of Clinical Studies, Ontario Veterinary College, University of Guelph, Ontario, Canada.
| | - Brigitte A Brisson
- Departments of Clinical Studies, Ontario Veterinary College, University of Guelph, Ontario, Canada
| | - Russell S Fraser
- Departments of Pathobiology, Ontario Veterinary College, University of Guelph, Ontario, Canada
| | - Dale A Smith
- Departments of Pathobiology, Ontario Veterinary College, University of Guelph, Ontario, Canada
| |
Collapse
|
7
|
Park ES, Suzuki M, Kimura M, Mizutani H, Saito R, Kubota N, Hasuike Y, Okajima J, Kasai H, Sato Y, Nakajima N, Maruyama K, Imaoka K, Morikawa S. Epidemiological and pathological study of feline morbillivirus infection in domestic cats in Japan. BMC Vet Res 2016; 12:228. [PMID: 27724851 PMCID: PMC5057488 DOI: 10.1186/s12917-016-0853-y] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Accepted: 10/01/2016] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Feline morbillivirus (FmoPV) is a novel paramyxovirus found to infect domestic cats. FmoPV has been isolated in several countries in Asia and Europe and is considered to have genetic diversity. Also, it is suspected to be associated with feline renal diseases including tubulointerstitial nephritis (TIN), which affects domestic cats with a high incidence rate. RESULTS To clarify the state of FmoPV infection among domestic cats in Japan, an epidemiological survey was conducted. Twenty-one out of 100 cats were found to have serum antibodies (Ab) against FmoPV-N protein by indirect immunofluorescence assay (IF) using FmoPV-N protein-expressing HeLa cells. Twenty-two of the cats were positive for FmoPV RNA in the urine and/or renal tissues. In total, 29 cats were positive for Ab and/or viral RNA. These FmoPV-infected cats were classified into three different phases of infection: RNA+/Ab + (14 cats), RNA+/Ab- (8 cats) and RNA-/Ab + (7 cats). In immunohistochemistry (IHC), 19 out of 29 cats were positive for FmoPV-N protein in kidney tissues; however, the FmoPV-N protein was located in the inflammatory lesions with severe grade in only four out of the 19 cats. Since 15 out of 29 infected cats were positive for viral RNA and Ab, approximately half of the infected cats were persistently infected with FmoPV. CONCLUSIONS A statistically significant difference was observed between infection of FmoPV and the presence of inflammatory changes in renal lesions, indicating a relationship between FmoPV infection and feline renal diseases. However, we could not obtain histopathological evidence of a relationship between FmoPV infection and TIN.
Collapse
Affiliation(s)
- Eun-Sil Park
- Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan
| | - Michio Suzuki
- Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan
| | - Masanobu Kimura
- Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan
| | - Hiroshi Mizutani
- Tokyo Metropolitan Animal Care and Consultation Center, Jounanjima Branch Office, Tokyo, 143-0002, Japan
| | - Ryuichi Saito
- Tokyo Metropolitan Animal Care and Consultation Center, Jounanjima Branch Office, Tokyo, 143-0002, Japan
| | - Nami Kubota
- Tokyo Metropolitan Animal Care and Consultation Center, Jounanjima Branch Office, Tokyo, 143-0002, Japan
| | - Youko Hasuike
- Tokyo Metropolitan Animal Care and Consultation Center, Jounanjima Branch Office, Tokyo, 143-0002, Japan
| | - Jungo Okajima
- Tokyo Metropolitan Animal Care and Consultation Center, Jounanjima Branch Office, Tokyo, 143-0002, Japan
| | - Hidemi Kasai
- Tokyo Metropolitan Animal Care and Consultation Center, Jounanjima Branch Office, Tokyo, 143-0002, Japan
| | - Yuko Sato
- Department of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan
| | - Noriko Nakajima
- Department of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan
| | - Keiji Maruyama
- Tokyo Metropolitan Animal Care and Consultation Center, Jounanjima Branch Office, Tokyo, 143-0002, Japan
| | - Koichi Imaoka
- Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan
| | - Shigeru Morikawa
- Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
| |
Collapse
|